Results
106
Companies which are more than 50% undervalued based on analyst price target.
106 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
PEUG | €74.90 | 2.5% | -28.7% | €1.9b | €115.00 | PE16.5x | E15.8% | 4.3% | Diversified Financials | ||
VLTSA | €7.67 | 7.6% | -1.3% | €1.0b | €12.01 | PE30.1x | E21.1% | n/a | Utilities | ||
ETL | €1.31 | -24.0% | -68.6% | €621.5m | €2.20 | PS0.5x | E95.9% | 0% | Media | ||
EQS | €38.00 | 2.3% | -22.1% | €571.2m | €58.83 | PE13.5x | E9.1% | 3.3% | Healthcare | ||
VLA | €3.39 | 0.3% | -6.9% | €550.4m | €6.86 | PS3.5x | E2.1% | n/a | Pharmaceuticals & Biotech | ||
ATO | €0.0029 | 38.1% | -99.9% | €519.2m | €0.09 | PS0.05x | E121.4% | 0% | Software | ||
MEDCL New | €14.30 | -4.8% | 64.0% | €425.5m | €23.17 | PS32.2x | E114.3% | n/a | Pharmaceuticals & Biotech | ||
ABVX | €6.56 | 3.5% | -43.4% | €415.6m | €29.34 | PS46x | E19.5% | n/a | Pharmaceuticals & Biotech | ||
WAGA | €14.36 | -0.1% | -34.7% | €354.6m | €27.75 | PS7.9x | E-9.6% | n/a | Energy | ||
CO | €0.82 | -8.4% | -98.1% | €330.0m | €2.08 | PE0.2x | E-81.0% | 0% | Consumer Retailing | ||
GBT | €25.55 | 0.6% | -15.5% | €322.2m | €39.13 | PE9.8x | E18.1% | 2.0% | Healthcare | ||
IVA | €2.27 | 0.2% | -29.1% | €217.2m | €7.02 | PS11.3x | E31.7% | n/a | Pharmaceuticals & Biotech | ||
ALSEN | €0.63 | 1.3% | -21.6% | €189.2m | €2.50 | PS30.8x | E-31.5% | n/a | Pharmaceuticals & Biotech | ||
GNFT | €3.76 | -0.1% | 7.6% | €187.2m | €9.45 | PE8.4x | E45.2% | n/a | Pharmaceuticals & Biotech | ||
IPH | €2.09 | 7.5% | -8.5% | €175.2m | €6.14 | PS5.2x | E50.9% | n/a | Pharmaceuticals & Biotech | ||
PARP | €17.85 | 3.5% | -14.6% | €171.6m | €30.80 | PE156x | n/a | 1.8% | Consumer Services | ||
NANO | €3.62 | -6.0% | -44.9% | €171.6m | €11.17 | PS4.1x | E36.5% | n/a | Pharmaceuticals & Biotech | ||
ALFPC | €101.00 | -0.5% | -11.0% | €166.0m | €174.50 | PE5x | E-30.6% | 2.2% | Consumer Durables | ||
LHYFE | €3.44 | -3.2% | -25.2% | €164.8m | €5.22 | PS63.3x | E21.1% | n/a | Energy | ||
ALPUL | €19.44 | -0.4% | 45.3% | €160.1m | €30.78 | PE11.7x | E-22.2% | 0% | Media | ||
ALFRE | €2.80 | 6.1% | -15.2% | €158.2m | €4.70 | PE10.2x | E15.3% | 2.9% | Commercial Services | ||
OSE | €6.98 | 11.1% | 94.2% | €152.7m | €15.37 | PE3.3x | E-77.4% | n/a | Pharmaceuticals & Biotech | ||
ARVEN | €4.00 | -1.2% | -51.5% | €139.1m | €8.50 | PS13.8x | E45.5% | n/a | Utilities | ||
AL2SI | €5.12 | 21.3% | 0.8% | €114.1m | €8.33 | PS0.9x | E72.9% | n/a | Tech |